223 related articles for article (PubMed ID: 15779424)
1. [Diabetes prevention program (metformin)].
Kusaka I; Nagasaka S
Nihon Rinsho; 2005 Feb; 63 Suppl 2():471-7. PubMed ID: 15779424
[No Abstract] [Full Text] [Related]
2. [Pathophysiological conditions progressing from impaired glucose tolerance: type 2 diabetes mellitus].
Asakura T; Ito Y
Nihon Rinsho; 2005 Feb; 63 Suppl 2():237-41. PubMed ID: 15779378
[No Abstract] [Full Text] [Related]
3. [Characteristic of metformin for treatment of impaired glucose tolerance].
Ishida W; Satoh J
Nihon Rinsho; 2005 Feb; 63 Suppl 2():433-7. PubMed ID: 15779418
[No Abstract] [Full Text] [Related]
4. [Japan Diabetes Prevention Program].
Sakane N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():488-92. PubMed ID: 15779427
[No Abstract] [Full Text] [Related]
5. [Diet therapy for impaired glucose tolerance].
Ogura M; Seino Y
Nihon Rinsho; 2005 Feb; 63 Suppl 2():503-8. PubMed ID: 15779430
[No Abstract] [Full Text] [Related]
6. [Treatment for patients with impaired glucose tolerance].
Tawaramoto K; Kaku K
Nihon Rinsho; 2005 Feb; 63 Suppl 2():423-7. PubMed ID: 15779416
[No Abstract] [Full Text] [Related]
7. [The Da Qing IGT and Diabetes study].
Ayame H
Nihon Rinsho; 2005 Feb; 63 Suppl 2():499-502. PubMed ID: 15779429
[No Abstract] [Full Text] [Related]
8. [The Study TO Prevent Non-Insulin Dependent Diabetes Mellitus trial (acarbose)].
Nishimura R
Nihon Rinsho; 2005 Feb; 63 Suppl 2():478-82. PubMed ID: 15779425
[No Abstract] [Full Text] [Related]
9. [NAVIGATOR trial (nateglinide)].
Tsujii S
Nihon Rinsho; 2005 Feb; 63 Suppl 2():483-7. PubMed ID: 15779426
[No Abstract] [Full Text] [Related]
10. [Management of IGT education program at a hospital and its primary prevention effect on diabetes mellitus].
Nunoi K; Fukui T; Sato Y; Sakuragi R
Nihon Rinsho; 2005 Feb; 63 Suppl 2():582-7. PubMed ID: 15779444
[No Abstract] [Full Text] [Related]
11. [Malmö Feasibility Study (Sweden)].
Tsujii S
Nihon Rinsho; 2005 Feb; 63 Suppl 2():493-8. PubMed ID: 15779428
[No Abstract] [Full Text] [Related]
12. What's preventing us from preventing type 2 diabetes?
Fradkin JE; Roberts BT; Rodgers GP
N Engl J Med; 2012 Sep; 367(13):1177-9. PubMed ID: 23013070
[No Abstract] [Full Text] [Related]
13. [The internal and external cohort studies about impaired glucose tolerance].
Shibazaki S; Nagai M
Nihon Rinsho; 2005 Feb; 63 Suppl 2():82-6. PubMed ID: 15779350
[No Abstract] [Full Text] [Related]
14. [Diabetic campaign in Toyama: framework and program for organized cooperation in regional diabetes care and prevention].
Fujikawa M; Kano B; Shiiba S; Kobayashi M
Nihon Rinsho; 2005 Feb; 63 Suppl 2():565-77. PubMed ID: 15779442
[No Abstract] [Full Text] [Related]
15. [In high risk for diabetes should drugs be used for prevention? (interview by Dr. Judith Neumaier)].
Hanefeld M
MMW Fortschr Med; 2002 Oct; 144(40):12. PubMed ID: 12440285
[No Abstract] [Full Text] [Related]
16. Diabetes prevention programs.
Ramachandran A; Snehalatha C
Med Clin North Am; 2011 Mar; 95(2):353-72, viii. PubMed ID: 21281838
[TBL] [Abstract][Full Text] [Related]
17. [Development of health-risk appraisal in impaired glucose tolerance].
Sakane N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():614-9. PubMed ID: 15779449
[No Abstract] [Full Text] [Related]
18. [Effects of acarbose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
Sakamoto N; Tajima N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():451-6. PubMed ID: 15779421
[No Abstract] [Full Text] [Related]
19. Diabetes prevention program: education is vital.
Fain JA
Diabetes Educ; 2002; 28(4):474. PubMed ID: 12224190
[No Abstract] [Full Text] [Related]
20. Reduction of body iron stores and the prevention of type 2 diabetes.
Mascitelli L; Pezzetta F
Am J Med; 2007 Jan; 120(1):e13; author reply e15. PubMed ID: 17208061
[No Abstract] [Full Text] [Related]
[Next] [New Search]
